Events

Innovative Software for Molecular Discovery and Design

Overview

Learn about the essential computational tools to advance your projects. As well as presenting Cresset technology and applications, Syngene will discuss how they have applied Cresset applications to their projects, and we will share the work of existing customers, as presented at the Cresset User Group Meeting 2018.

Who should attend by role?

Computational chemist • Medicinal chemist • Synthetic chemist • Head of discovery • Head of modeling and simulation • Head of R&D • Research Scientist

Who should attend by organization?

Academia • Pharmaceutical • Biotech • Agrochemical

Program

09:00 Registration
09:30 Introduction to Cresset Science and Software Robert Scoffin, Cresset
10:00 Structure-based Design Using Flare Suneel Kumar, Cresset
11:00 Break
11:30 To be confirmed Rushith Kumar Anumula, Syngene
12:15

How Cresset Customers Use Our Software: A Review of Presentations from the Cresset User Group Meeting 2018

Compound Library Design Using In-Silico Approach for Collaborative Drug Discovery


Pushing the Boundaries of Binding Free Energy Prediction Methods

Robert Scoffin, Cresset
13:00 Lunch
13:45 SAR Methods in Forge Suneel Kumar, Cresset
14:45 Break
15:15 Hands-on software workshop: Electrostatic Complementarity™ in Flare Suneel Kumar, Cresset
16:45 Discussion led by meeting chair Robert Scoffin, Cresset
17:00 Close

Robert Scoffin

Dr Robert Scoffin is an experienced entrepreneur and senior executive within the life sciences software industry. Following a D.Phil gained from Oxford University, he worked for eight years at Oxford Molecular, seeing the company grow from 15 to 250 people and a successful floatation on the London Stock Exchange.

In 1998 Rob joined CambridgeSoft, at the time a well-known creator of desktop chemistry software, with the remit to help grow an Enterprise Informatics business with particular focus on the European market. He achieved great success with CambridgeSoft over a twelve year period, managing European Operations with responsibility for marketing, sales, support and professional services. Rob oversaw the growth of the business to more than $18m in annual turnover, being responsible for a team of more than 30 direct employees and more than 65 contract staff.

Rob joined Cresset as CEO in 2010. During the time he has been leading the team, Cresset has further developed its software and services from a very solid customer base, into a high-growth and profitable business.

In 2014 Rob co-founded Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling.

Suneel Kumar

Dr Suneel Kumar gained a PhD in Computational Chemistry from the Jawaharlal Nehru Technological University, with specific focus on ‘Rational Design, Synthesis, and Pharmacological Screening of Fibroblast Growth Factor Receptor 1 Inhibitors’.

He started his career with GVKBIO where he provided computational chemistry support to multiple drug discovery projects. Suneel then moved AMRI Global as Senior Research Scientist, and Sai Life Sciences as Associate Principal Scientist where he established the computational chemistry department and supported internal and external projects.

Suneel has 14+ years of industrial experience as computational chemist, with a strong working background in structure and analogue-based drug design approaches, data analytics, materials science and informatics. In 2018 Suneel joined Cresset as Application Scientist.

Rushith Kumar Anumula, Syngene

To follow